Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 60 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

8%

5 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A
40(87.0%)
Phase 4
5(10.9%)
Phase 2
1(2.2%)
46Total
N/A(40)
Phase 4(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (60)

Showing 20 of 60 trials
NCT05552820Not ApplicableCompleted

Electroacupuncture for Mild-to-moderate Dry Eye

Role: collaborator

NCT06563700Not ApplicableActive Not Recruiting

Novel Lenses for Myopia Progression Trial

Role: lead

NCT07535658Not ApplicableNot Yet Recruiting

Efficacy of Multi-Type Photolithography Flat Microstructure Lenses for Childhood Myopia Control

Role: lead

NCT04699357Not ApplicableCompleted

The Effect and Safety of Different Doses of Atropine on Myopic Progression of Highly Myopic Children: Multi-centered Randomized Clinical Trial

Role: lead

NCT07375589Not ApplicableCompleted

LED Low-Intensity Red Light for Myopia Control in Youth: Efficacy and Safety Study

Role: lead

NCT07312214Not ApplicableRecruiting

LED Red Light in Modulating Choroidal Microcirculation to Retard Retinal Atrophy in Pathological Myopia

Role: lead

NCT05770661Recruiting

China Axial Length Study

Role: lead

NCT07284147Not ApplicableEnrolling By Invitation

3D Designed Defocus Lenses on Myopia Control in Children and Adolescents

Role: lead

NCT06860737Not ApplicableActive Not Recruiting

A Randomized Clinical Trial on the Effectiveness of Novel Plano Spectacle Lenses on Myopia Prevention in Pre-myopic Children

Role: lead

NCT06927388Not ApplicableActive Not Recruiting

Myopia Progression With Freeform Myopia Control Spectacles

Role: lead

NCT05894382Not ApplicableActive Not Recruiting

Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control

Role: lead

NCT07176949Not ApplicableRecruiting

Early-Onset Myopia Intervention Project

Role: lead

NCT07120737Not ApplicableNot Yet Recruiting

Efficacy and Safety of Spectacle Lenses With H.A.L.T. MAX Technology on High Myopia Control in Children and Adolescents

Role: lead

NCT06305143Phase 4Active Not Recruiting

Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy

Role: lead

NCT06995911Not ApplicableNot Yet Recruiting

Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children

Role: lead

NCT06232616Not ApplicableEnrolling By Invitation

Vitrectomy Combined With Intravitreal Dexamethasone Implant for Idiopathic Epiretinal Membrane With Macular Oedema

Role: lead

NCT06927414Not ApplicableActive Not Recruiting

Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents

Role: lead

NCT06926556Not ApplicableCompleted

Different Microlenses Array for Controlling Myopia Progression in Children and Adolescents

Role: lead

NCT05550740Not ApplicableActive Not Recruiting

Repeated Low-Level Red-Light Therapy for Shortening Axial Length

Role: lead

NCT06877494Phase 2Completed

the Effects of Fish Oil Supplements on Choroidal Thickness and Blood Flow Perfusion in Children and Adolescents

Role: lead